Department of Psychology, University of Maryland, College Park, College Park, MD, USA.
Department of Psychology, University of Maryland, College Park, College Park, MD, USA.
J Subst Abuse Treat. 2022 Jul;138:108721. doi: 10.1016/j.jsat.2022.108721. Epub 2022 Jan 16.
A substantial, national need exists for culturally acceptable, accessible opioid use disorder (OUD) treatment. Medication for opioid use disorder (MOUD) is regarded as effective in treating OUD; however, retention in MOUD programs remains low nationally. One known barrier to MOUD retention is stigma, particularly within ethno-racial minority communities. Peer recovery specialists (PRSs), individuals with shared experience in substance use and recovery, may be particularly well suited to support patients in MOUD treatment, and may have capacity to play a key role in decreasing stigma-related barriers to MOUD retention.
This study used qualitative methods to solicit feedback on how patients receiving methadone treatment (MT) experience stigma (i.e., toward substance use [SU] and MT). Study staff also gathered information regarding how a PRS role may reduce stigma and improve retention in care, including barriers and facilitators to the PRS role shifting stigma. Study staff conducted semi-structured qualitative interviews and focus groups (N = 32) with staff and patients receiving MT at an opioid treatment program as well as PRSs in Baltimore.
Participants identified experiences of internalized, as well as enacted and anticipated, MT and SU stigma, and described these as barriers to treatment. Participants also identified opportunities for PRSs to shift stigma-related barriers for patients receiving MT through unique aspects of the PRS role, such as their shared lived experience.
Reducing stigma surrounding SUD and MT is critical for improving MOUD outcomes, and future research may consider how the PRS role can support this effort.
在文化上可接受且易于获取的阿片类药物使用障碍(OUD)治疗在全国范围内有很大的需求。药物治疗阿片类药物使用障碍(MOUD)被认为是治疗 OUD 的有效方法;然而,全国范围内 MOUD 项目的保留率仍然很低。众所周知,MOUD 保留率的一个障碍是污名化,特别是在族裔少数群体社区中。同伴康复专家(PRS)是指在药物使用和康复方面有共同经历的个体,他们可能特别适合支持接受 MOUD 治疗的患者,并可能在减少与污名相关的 MOUD 保留障碍方面发挥关键作用。
本研究采用定性方法,征求接受美沙酮治疗(MT)的患者对污名体验(即对药物使用和 MT 的污名)的反馈意见。研究人员还收集了关于 PRS 角色如何减少污名化并改善护理保留率的信息,包括 PRS 角色转变污名化的障碍和促进因素。研究人员在巴尔的摩的一个阿片类药物治疗项目中对接受 MT 的工作人员和患者以及 PRS 进行了半结构化定性访谈和焦点小组(N=32)。
参与者确定了内化的、实施的和预期的 MT 和 SU 污名化的经历,并将这些经历描述为治疗的障碍。参与者还确定了 PRS 通过 PRS 角色的独特方面为接受 MT 的患者转变与污名相关的障碍的机会,例如他们共同的生活经历。
减少 SUD 和 MT 周围的污名化对于改善 MOUD 结果至关重要,未来的研究可能会考虑 PRS 角色如何支持这一努力。